GKB OPHTHALMICS LTD. - 533212 - Resolutions Passed By The Board Of Directors Of The Company Through Circulation.
This is to inform that the Board of Directors of the Company transacted the enclosed matters by resolution passed through Circulation on March 30, 2023. Kindly take the information on record. GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations, 2015), intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF) , has purchased 40 equity shares aggregating to Rs. 4309.71/- from 27.02.2023 to 03.01.2023 on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from KrishnaGopal Gupta and Sons- HUF. Please acknowledge and take the same on record. GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, the 'Trading Window' for dealing/trading in the shares of the Company shall remain closed from April 01, 2023, till the completion of 48 hours after the declaration of the audited financial results of the Company, for the quarter and financial year ended March 31, 2023. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further, the date of Board Meeting at which the said results will be considered, shall be intimated in due course of time. Kindly take the information on record. GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Demise
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , we would like to inform about the sad demise of Mr. Sadashiv Shet (DIN : 02227102), Non-Executive Independent Director of the Company on Wednesday, March 22, 2023. Mr. Sadashiv Shet was re-appointed as an Independent Director of the Company for second term of 5 consecutive years w.e.f May 23, 2020 to May 22, 2025. He was the Chairman of the Audit Committee and a member of the Nomination and Remuneration Committee. Mr. Sadashiv Shet's sudden passing away is a great loss to the Company. All the directors and the management of the Company express their deepest condolences to his family. This is for your kind information & record. GKB OPHTHALMICS LTD. - 533212 - OUTCOME OF INDEPENDENT DIRECTORS'' MEETING HELD ON MARCH 13, 2023
A separate meeting of the Independent Directors of the Company for the year 2022-23, was held, pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and section 149(8) of the Companies Act, 2013, read with Schedule IV (VII). The following Independent Directors were present at the meeting: 1. Mr. Sadashiv Shet 2. Mr. Anil Palekar 3. Mrs. Shashi Katreddi Since all the Independent Directors were present, no leave of absence was granted. The Independent Directors in their Meeting held today: 1.Reviewed the performance of Non-Independent Directors and the Board as a whole. 2.Reviewed the performance of the Chairperson of the Company, taking into account the views of the Executive Director and Non-Executive Directors. 3.Assessed the quality, quantity and timeliness of the flow of information between the Company''s management and the Board. The Independent Directors'' Meeting started at 10:00 A.M. and ended at 10:40 A.M., on the same day. GKB OPHTHALMICS LTD. - 533212 - Clarification On Price Movement
We refer to your e-mail L/SURV/ONL/PV/VK/ 2022-2023/3038, dated March 06, 2023, seeking clarification, on significant movement in the share price of our Company, in the recent past. In order to enable the investors to make well informed investment decisions, the Company has been making to the Exchange, adequate and accurate disclosures of all material events, information, etc., from time to time, that have a bearing on operation / performance of the Company which includes all Price Sensitive Information as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has no pending announcements, that may have a bearing on price / volume behaviour of the Script that is pending disclosure, to the Stock Exchange, at this point of time. Hope we have clarified the matter. We request you to kindly take the same on record. GKB OPHTHALMICS LTD. - 533212 - Clarification sought from GKB Ophthalmics Ltd
The Exchange has sought clarification from GKB Ophthalmics Ltd on March 6, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. GKB OPHTHALMICS LTD. - 533212 - Intimation Of Separate Meeting Of Independent Directors To Be Held On Monday, March 13, 2023.
Pursuant to Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a separate Meeting of the Independent Directors of the Company is scheduled to be held on Monday, March 13, 2023 at the Registered office of the Company situated at Plot No. 16-A , Tivim Industrial Estate, Mapusa, Goa , 403 526, to consider the following business: 1. To review the performance of Non-Independent Directors and the Board as a whole; 2. To review the performance of the Chairperson of the Company, taking into account the views of Executive Directors and Non-Executive Directors; 3. To assess the quality, quantity and timeliness of flow of information between the Company management and the Board that is necessary for the Board to effectively and reasonably perform their duties; 4. Any other business with the permission of chair. GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2022, published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated February 16, 2023. GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations , 2015
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, we would like to inform you that the Audit Committee in their meeting held on February 14, 2023, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there was no utilization of funds, during the quarter ended December 31, 2022. Enclosed please find the Statement as per the format, giving details of the same.